These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 29784451)

  • 21. Prognostic significance of HPV status in the re-irradiation of recurrent and second primary cancers of the head and neck.
    Velez MA; Wang PC; Hsu S; Chin R; Beron P; Abemayor E; St John M; Chen AM
    Am J Otolaryngol; 2018; 39(3):257-260. PubMed ID: 29433815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
    León X; Agüero A; López M; García J; Farré N; López-Pousa A; Quer M
    Auris Nasus Larynx; 2015 Apr; 42(2):145-9. PubMed ID: 25459494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiochemotherapy with Paclitaxel for Recurrent Previously Irradiated Squamous Cell Carcinoma of the Head and Neck.
    Rades D; Seidl D; Wollenberg B; Schild SE; Hakim SG
    Anticancer Res; 2016 Oct; 36(10):5463-5468. PubMed ID: 27798916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
    Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
    Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.
    Rambeau A; Bastit V; Thureau S; Thariat J; Moldovan C; Roge M; Babin E; Gery B; Di Fiore F; Florescu C; Clatot F
    Oral Oncol; 2019 Jun; 93():46-51. PubMed ID: 31109695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
    Harrington K; Temam S; Mehanna H; D'Cruz A; Jain M; D'Onofrio I; Manikhas G; Horvath Z; Sun Y; Dietzsch S; Dubinsky P; Holeckova P; El-Hariry I; Franklin N; Biswas-Baldwin N; Legenne P; Wissel P; Netherway T; Farrell J; Ellis C; Wang-Silvanto J; Amonkar M; Ahmed N; Santillana S; Bourhis J
    J Clin Oncol; 2015 Dec; 33(35):4202-9. PubMed ID: 26527790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re-irradiation for head and neck squamous cell carcinoma.
    Benson R; Giridhar P; Venkatesulu BP; Mallick S; Raza MW; Rath GK
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):1-9. PubMed ID: 27595192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-irradiation Using Intensity-modulated Radiotherapy for Recurrent and Second Primary Head and Neck Cancer.
    Choi SH; Chang JS; Choi J; Park SH; Keum KC; Park KR; Lee CG
    Anticancer Res; 2018 May; 38(5):3165-3173. PubMed ID: 29715158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of postoperative reirradiation combined with chemotherapy after salvage surgery compared with salvage surgery alone in head and neck carcinoma.
    Janot F; de Raucourt D; Benhamou E; Ferron C; Dolivet G; Bensadoun RJ; Hamoir M; Géry B; Julieron M; Castaing M; Bardet E; Grégoire V; Bourhis J
    J Clin Oncol; 2008 Dec; 26(34):5518-23. PubMed ID: 18936479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concurrent Radiotherapy With Cetuximab or Platinum-based Chemotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    Lu SM; Lien WW
    Am J Clin Oncol; 2018 Jan; 41(1):95-99. PubMed ID: 26353121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unresectable Recurrent Squamous Cell Carcinoma of the Temporal Bone Treated by Induction Chemotherapy Followed by Concurrent Chemo-Reirradiation: A Case Report and Review of the Literature.
    Kun M; Xinxin Z; Feifan Z; Lin M
    Otol Neurotol; 2015 Sep; 36(9):1543-6. PubMed ID: 26208130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience.
    Al-Wassia R; Vakilian S; Holly C; Sultanem K; Shenouda G
    J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):31. PubMed ID: 26330008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.
    Montejo ME; Shrieve DC; Bentz BG; Hunt JP; Buchman LO; Agarwal N; Hitchcock YJ
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e845-52. PubMed ID: 21167654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck.
    Spencer SA; Harris J; Wheeler RH; Machtay M; Schultz C; Spanos W; Rotman M; Meredith R; Ang KK
    Head Neck; 2008 Mar; 30(3):281-8. PubMed ID: 17764087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.
    Patil V; Noronha V; Joshi A; Menon N; Mathrudev V; Bhattacharjee A; Chandrasekharan A; Vallathol D; Dsouza H; Srinivas S; Mandal T; Chaturvedi P; Chaukar D; Pai P; Nair S; Thiagrajan S; Laskar S; Nawale K; Babanrao Dhumal S; Tambe R; Banavali S; Prabhash K
    Oral Oncol; 2022 May; 128():105816. PubMed ID: 35367787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study.
    Kakria A; Rawat S; Bhutani R; Gupta G; Devnani B; Wahi IK; Ahlawat P
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):129-34. PubMed ID: 25132076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of patient-reported quality-of-life outcomes following SBRT ± cetuximab for locally-recurrent, previously-irradiated head and neck cancer.
    Vargo JA; Heron DE; Ferris RL; Rwigema JC; Wegner RE; Kalash R; Ohr J; Kubicek GJ; Burton S
    Radiother Oncol; 2012 Jul; 104(1):91-5. PubMed ID: 22677037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial.
    Bourhis J; Lapeyre M; Tortochaux J; Lusinchi A; Etessami A; Ducourtieux M; Geoffrois L; Domenge C; Verrelle P; Wibault P; Janot F; Temam S; Blanchard P; Tao YG; Auperin A
    Radiother Oncol; 2011 Jul; 100(1):56-61. PubMed ID: 21831465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.